Clicky

Cytek Biosciences, Inc.(CTKB)

Description: Cytek Biosciences, Inc. engages in the manufacture and sale of cell analysis solutions for clinical and biomedical research in the fields of drug discovery, genomics, immuno-oncology, immuno-profiling, infectious diseases, inflammatory diseases, and multi-site standardization applications. Its instruments include the Aurora and Northern Lights systems, which are flow cytometers to deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also offers cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. Its customers include pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. Cytek Biosciences, Inc. was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. The company was incorporated in 2014 and is headquartered in Fremont, California.


Keywords: Medicine Laser Biology Infectious Diseases Antibodies Drug Discovery Cell Biology Genomics Inflammatory Diseases Medical Test Laboratory Techniques Blood Test Flow Cytometry Clinical Pathology

Home Page: cytekbio.com

CTKB Technical Analysis

47215 Lakeview Boulevard
Fremont, CA 94538
United States
Phone: 877 922 9835


Officers

Name Title
Dr. Wenbin Jiang Ph.D. Pres, CEO & Chairman
Mr. Patrik Sebastian Jeanmonod Chief Financial Officer
Dr. Ming Yan Ph.D. CTO & Director
Dr. Allen B. Poirson Ph.D. Sr. VP of Bus. & Corp. Devel.
Mr. Chris Williams Chief Operating Officer
Mr. Mark Edinger VP of Scientific Affairs
Mr. Paul D. Goodson Head of Investor Relations
Ms. Valerie T. Barnett J.D. Gen. Counsel & Corp. Sec.
Ms. Connie Wedel Chief People Officer
Mr. Todd Garland Chief Commercial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 370.3704
Trailing PE: 0
Price-to-Book MRQ: 3.6527
Price-to-Sales TTM: 9.4122
IPO Date: 2021-07-23
Fiscal Year End: December
Full Time Employees: 574
Back to stocks